Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Structural biology

Meet the B family

The first crystal structures of class B G-protein-coupled receptors have been solved. They reveal features that might inform drug-development strategies for diseases ranging from osteoporosis to diabetes. See Articles p.438 & p.444

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Structural features of class B GPCRs.

Notes

  1. *This article and the papers under discussion3,4 were published online on 17 July.

References

  1. Fredriksson, R., Lagerström, M. C., Lundin, L. G. & Schiöth, H. B. Mol. Pharmacol. 63, 1256–1272 (2003).

    Article  CAS  Google Scholar 

  2. Overington, J. P., Al-Lazikani, B. & Hopkins, A. L. Nature Rev. Drug Discov. 5, 993–996 (2006).

    Article  CAS  Google Scholar 

  3. Hollenstein, K. et al. Nature 499, 438–443 (2013).

    Article  ADS  CAS  Google Scholar 

  4. Siu, F. Y. et al. Nature 499, 444–449 (2013).

    Article  ADS  CAS  Google Scholar 

  5. Dong, M. et al. FASEB J. 26, 5092–5105 (2012).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Patrick M. Sexton or Denise Wootten.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sexton, P., Wootten, D. Meet the B family. Nature 499, 417–418 (2013). https://doi.org/10.1038/nature12413

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature12413

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research